Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOnconetix Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$4,505.00 | -$4,505.00 | -$4,505.00 |
| Q2 2026 | 1 | -$45,050.00 | -$45,050.00 | -$45,050.00 |
| Q3 2026 | 1 | -$34,850.00 | -$34,850.00 | -$34,850.00 |
| Q1 2027 | 1 | -$20,400.00 | -$20,400.00 | -$20,400.00 |
| Q2 2027 | 1 | -$32,300.00 | -$32,300.00 | -$32,300.00 |
| Q3 2027 | 1 | -$35,700.00 | -$35,700.00 | -$35,700.00 |
Onconetix Inc Earnings Date And Information
Onconetix Inc last posted its earnings results on Thursday, April 11th, 2024. The company reported $-0.28571 earnings per share for the quarter, topping analysts' consensus estimates of $-3570 by $3569.71429. The company had revenue of 21.46 K for the quarter and had revenue of 815.37 K for the year. Onconetix Inc has generated $-5 earnings per share over the last year ($-4.73 diluted earnings per share) and currently has a price-to-earnings ratio of -0.11. Onconetix Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Onconetix Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/13/2026 | Q1 2026 | N/A | -$6.71 | N/A | N/A | $21.46 K |
| 03/13/2026 | Q4 2025 | N/A | $1.04 | N/A | N/A | $303.60 K |
| 11/13/2025 | Q3 2025 | N/A | -$1.79 | N/A | N/A | $303.65 K |
| 08/14/2025 | Q2 2025 | N/A | -$1.36 | N/A | N/A | $106.49 K |
| 06/12/2025 | Q1 2025 | N/A | -$514.86 | N/A | N/A | $101.63 K |
| 06/02/2025 | Q4 2024 | N/A | -$4.97 | N/A | N/A | $711.98 K |
| 12/09/2024 | Q3 2024 | N/A | -$0.84 | N/A | N/A | $406.86 K |
| 08/29/2024 | Q2 2024 | N/A | -$0.18 | N/A | N/A | $704.85 K |
| 05/20/2024 | Q1 2024 | N/A | -$0.14 | N/A | N/A | $700.43 K |
| 04/11/2024 | Q4 2023 | -$3,570.00 | -$0.29 | 3569.71 | $58.00 K | $58.47 K |
| 09/29/2023 | Q3 2023 | N/A | -$0.09 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.12 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.05 | N/A | N/A | $0 |
| 12/29/2022 | Q4 2022 | N/A | -$0.06 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | -$0.08 | N/A | N/A | $0 |
| 06/28/2022 | Q2 2022 | N/A | -$0.10 | N/A | N/A | $0 |
| 03/29/2022 | Q1 2022 | N/A | -$0.09 | N/A | N/A | $0 |
| 12/29/2021 | Q4 2021 | N/A | -$0.03 | N/A | N/A | $0 |
| 09/28/2021 | Q3 2021 | N/A | -$0.03 | N/A | N/A | $0 |
| 03/29/2021 | Q1 2021 | N/A | -$0.03 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Onconetix Inc Earnings: FAQ's
In the previous quarter, Onconetix Inc (:ONCO) reported $-0.28571 earnings per share (EPS) to beat the analysts' consensus estimate of $-3570 by $3569.71429.
The conference call for Onconetix Inc's latest earnings report can be listened to online.
The conference call transcript for Onconetix Inc's latest earnings report can be read online.
Onconetix Inc (:ONCO) has a recorded annual revenue of $815.37 K.
Onconetix Inc (:ONCO) has a recorded net income of $-14,032,342.Onconetix Inc has generated $-4.73 earnings per share over the last four quarters.
Onconetix Inc (:ONCO) has a price-to-earnings ratio of -0.11 and price/earnings-to-growth ratio is -0.